Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: James Baker who wrote (462)	4/5/1998 9:58:00 PM
From: John McCarthy	Read Replies (2) \| Respond to of 569

James - Based on Prudential's Earnings Estimate of $0.76 for 1998 and $2.24 for 1999 here is my guesstimate of Gross Sales. Earnings Projections are from Prudential Securities (000) ------ 1998 ------ ------ 1999 ------ Gross Sales E.P.S. Gross Sales E.P.S $45,900 $0.76 $104,200 $2.24 =========== ======= =========== ====== To put it mildly, these numbers are staggering. I think it fairly clear what the game plan is: (1) Get HMO support. (2) Then Advertise SYNVISC on TV/PRINT. Lastly, please don't lose site of the fact that we will be getting $6.0 mil. in license fees from AHP in the 4th Qtr of 1998 and $7.0 mil. in license fees from CGEN - if they go ahead with HylaForm in the USA. THESE LICENSE FEES ARE NOT IN PRU'S E.P.S. $. In conclusion, I think the only stumbling block here is HMO support. Enjoy the ride! Regards, John